Teriparatide 560MCG/2.24ML pen 2.24ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9LZ1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,032
Award facts
- Contract value 100% obligated
- $25,032.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,032.33 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 micrograms per 2.24 milliliters in pen format. This firm fixed-price delivery order, awarded on January 20, 2026, with completion targeted for January 21, 2026, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone used primarily for osteoporosis treatment in patients at high risk for fractures, making this a critical pharmaceutical commodity for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. This primary IDC, valued at up to $999.99 million through December 31, 2031, provides a comprehensive global pharmaceutical support vehicle enabling the supply of a vast range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The competitive award of this and similar task orders demonstrates AmerisourceBergen's established capability to efficiently fulfill essential pharmaceutical requirements for military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F9LZ1?
SPE2DR26F9LZ1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9LZ1 worth?
The government has obligated $25,032 on SPE2DR26F9LZ1.
Is contract SPE2DR26F9LZ1 an order under another contract?
Yes. SPE2DR26F9LZ1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LZ1 competed?
The extent of competition for SPE2DR26F9LZ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award